Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology
PR Newswire -8 July 2014 - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of PreCision Dermatology, Inc. PreCision develops and markets high quality dermatology products with leading products such as Locoid, Hylatopic, and Clindagel.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.
Company Details
- Employees
- 13
- Founded
- 2010
- Address
- Cumberland, Ri 02864, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.valeant.com
- HQ
- Cumberland, RI
Precision Dermatology, Inc. Questions
Precision Dermatology, Inc.'s website is http://www.valeant.com
Precision Dermatology, Inc.'s LinkedIn profile is https://www.linkedin.com/company/precision-dermatology
Precision Dermatology, Inc. has
13 employees.
View email and phone details for 13
employees at Precision Dermatology, Inc..
Precision Dermatology, Inc.'s industry is
Pharmaceutical Manufacturing
Precision Dermatology, Inc.'s top competitors are
Chemistry Rx Compounding And Specialty Pharmacy,
Agi Dermatics,
Galderma,
Syros Pharmaceuticals,
Sknv,
Invo Aesthetics,
Anteage,
Hm Compounding,
Valeant Pharmaceuticals,
Senté.
Precision Dermatology, Inc.'s categories are Pharmaceutical Manufacturing
Precision Dermatology, Inc.'s founding year is 2010
